Client-Focused Investment Banking
At Vator Securities, we combine industry expertise, entrepreneurial precision, and genuine dedication to create real value for our clients. Our ambition is to be more than just an adviser – we aim to be an integral part of our clients’ journey to success.
Select transactions
Alligator Bioscience
SEK 280m Capital Raise
Q4 2024
Q-linea
SEK 225m Capital Raise
Q4 2024
Yabie
SEK 64m Capital Raise
Q2 2024
Moberg Pharma
SEK 336m Capital Raise
Q2 2024
ESTRID
SEK 93m Private Placement
Q4 2023
Immunovia
SEK 202.2m Rights Issue
Q1 2023
Verisec
Private Placement – Undisclosed Amount
Q4 2022
Rebelle
SEK 315m M&A
Q3 2022
Rebelle
SEK 200m IPO
Q1 2022
A3P Biomedical
110 MSEK Private Placement
Q4 2020
Immunovia
SEK 400m Directed Issue
Q2 2020
Xbrane
SEK 238m Capital Raise
Q2 2019